Terms: = Skin cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
35 results:
1. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Boateng ST; Roy T; Agbo ME; Mahmud MA; Banang-Mbeumi S; Chamcheu RN; Yadav RK; Bramwell M; Pham LK; Dang DD; Jackson KE; Nagalo BM; Hill RA; Efimova T; Fotie J; Chamcheu JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14418. PubMed ID: 38230791
[TBL] [Abstract] [Full Text] [Related]
2. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
[TBL] [Abstract] [Full Text] [Related]
3. Galectin-9 promotes natural killer cells activity
Rahmati A; Bigam S; Elahi S
Front Immunol; 2023; 14():1131379. PubMed ID: 37006235
[TBL] [Abstract] [Full Text] [Related]
4. Molecular profiling of core immune-escape genes highlights lck as an immune-related prognostic biomarker in melanoma.
Wang F; Zheng A; Zhang D; Zou T; Xiao M; Chen J; Wen B; Wen Q; Wu X; Li M; Du F; Chen Y; Zhao Y; Shen J; Xiang S; Li J; Deng S; Zhang Z; Yi T; Xiao Z
Front Immunol; 2022; 13():1024931. PubMed ID: 36341345
[TBL] [Abstract] [Full Text] [Related]
5. PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
Pan W; Scherlinger M; Yoshida N; Tsokos MG; Tsokos GC
J Immunol; 2022 Aug; 209(3):621-628. PubMed ID: 35831019
[TBL] [Abstract] [Full Text] [Related]
6. Association of Genetic Ancestry and Molecular Signatures with cancer Survival Disparities: A Pan-cancer Analysis.
Lee KK; Rishishwar L; Ban D; Nagar SD; Mariño-Ramírez L; McDonald JF; Jordan IK
Cancer Res; 2022 Apr; 82(7):1222-1233. PubMed ID: 35064017
[TBL] [Abstract] [Full Text] [Related]
7. Association Between Melanoma Detected During Routine skin Checks and Mortality.
Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
[TBL] [Abstract] [Full Text] [Related]
8. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
[TBL] [Abstract] [Full Text] [Related]
9. Spitz nevus with a novel TFG-NTRK2 fusion: The first case report of NTRK2-rearranged Spitz/Reed nevus.
Goto K; Pissaloux D; Tirode F; de la Fouchardière A
J Cutan Pathol; 2021 Sep; 48(9):1193-1196. PubMed ID: 33979462
[TBL] [Abstract] [Full Text] [Related]
10. GOPC-ROS1 mosaicism in agminated Spitz naevi: report of two cases.
Goto K; Pissaloux D; Kauer F; Huriet V; Tirode F; de la Fouchardière A
Virchows Arch; 2021 Sep; 479(3):559-564. PubMed ID: 33733342
[TBL] [Abstract] [Full Text] [Related]
11. Novel three-way complex rearrangement of TRPM1-PUM1-lck in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule.
Goto K; Pissaloux D; Durand L; Tirode F; Guillot B; de la Fouchardière A
Pigment Cell Melanoma Res; 2020 Sep; 33(5):767-772. PubMed ID: 32386465
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of the implant geometry in fractionated interstitial HDR breast brachytherapy using an electromagnetic tracking system.
Kellermeier M; Fietkau R; Strnad V; Bert C
Brachytherapy; 2018; 17(1):94-102. PubMed ID: 29146103
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung cancer.
Sakamoto S; Yamada T; Terazaki Y; Yoshiyama K; Sugawara S; Takamori S; Matsueda S; Shichijo S; Yamada A; Noguchi M; Itoh K; Hattori N; Kohno N; Sasada T
Clin Lung Cancer; 2017 Nov; 18(6):e385-e394. PubMed ID: 28416261
[TBL] [Abstract] [Full Text] [Related]
14. Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network
Cell; 2015 Jun; 161(7):1681-96. PubMed ID: 26091043
[TBL] [Abstract] [Full Text] [Related]
15. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract] [Full Text] [Related]
16. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
17. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
[TBL] [Abstract] [Full Text] [Related]
18. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.
Karia PS; Han J; Schmults CD
J Am Acad Dermatol; 2013 Jun; 68(6):957-66. PubMed ID: 23375456
[TBL] [Abstract] [Full Text] [Related]
19. A phase 2 trial of dasatinib in advanced melanoma.
Kluger HM; Dudek AZ; McCann C; Ritacco J; Southard N; Jilaveanu LB; Molinaro A; Sznol M
Cancer; 2011 May; 117(10):2202-8. PubMed ID: 21523734
[TBL] [Abstract] [Full Text] [Related]
20. Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
Su Y; Jackson EK; Gorelik E
Cancer Immunol Immunother; 2011 Jan; 60(1):111-22. PubMed ID: 20960188
[TBL] [Abstract] [Full Text] [Related]
[Next]
